Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024
Compare Balance Sheet Results of Kabra Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
23.71
6.83
16.88
247.14%
Share Warrants & Outstandings
Total Reserve
0.95
1.91
-0.96
-50.26%
Shareholder's Funds
24.65
8.74
15.91
182.04%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
-0.09
0.09
100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.22
-0.22
-100.00%
Total Non-Current Liabilities
0.00
0.13
-0.13
-100.00%
Current Liabilities
Trade Payables
0.00
11.96
-11.96
-100.00%
Other Current Liabilities
0.14
0.12
0.02
16.67%
Short Term Borrowings
0.44
0.00
0.44
0.00%
Short Term Provisions
0.00
0.53
-0.53
-100.00%
Total Current Liabilities
0.57
12.61
-12.04
-95.48%
Total Liabilities
25.23
21.47
3.76
17.51%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.05
15.35
-15.30
-99.67%
Less: Accumulated Depreciation
0.01
3.04
-3.03
-99.67%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
12.31
-12.27
-99.68%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.02
0.06
-0.04
-66.67%
Other Non Current Assets
0.00
0.88
-0.88
-100.00%
Total Non-Current Assets
0.07
13.26
-13.19
-99.47%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
3.06
-3.06
-100.00%
Sundry Debtors
0.60
3.11
-2.51
-80.71%
Cash and Bank
21.30
0.36
20.94
5,816.67%
Other Current Assets
0.00
1.48
-1.48
-100.00%
Short Term Loans and Advances
3.26
0.20
3.06
1,530.00%
Total Current Assets
25.16
8.21
16.95
206.46%
Net Current Assets (Including Current Investments)
24.59
-4.40
28.99
658.86%
Total Current Assets Excluding Current Investments
25.16
8.21
16.95
206.46%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
25.23
21.47
3.76
17.51%
Contingent Liabilities
0.49
0.16
0.33
206.25%
Total Debt
0.44
0.00
0.44
0.00%
Book Value per share (adjusted)
10.40
6.58
3.82
58.05%
Annual - Borrowings
Borrowings 0.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2025Figures in Cr
No Fixed Assets in the last few periods;
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 25.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024
